JP2022533463A5 - - Google Patents
Info
- Publication number
- JP2022533463A5 JP2022533463A5 JP2021569958A JP2021569958A JP2022533463A5 JP 2022533463 A5 JP2022533463 A5 JP 2022533463A5 JP 2021569958 A JP2021569958 A JP 2021569958A JP 2021569958 A JP2021569958 A JP 2021569958A JP 2022533463 A5 JP2022533463 A5 JP 2022533463A5
- Authority
- JP
- Japan
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2025071092A JP2025118693A (ja) | 2019-05-23 | 2025-04-23 | エンザルタミドを含むナノ粒子 |
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP19176304.4 | 2019-05-23 | ||
| EP19176304 | 2019-05-23 | ||
| EP19209182 | 2019-11-14 | ||
| EP19209182.5 | 2019-11-14 | ||
| PCT/EP2020/064268 WO2020234448A1 (en) | 2019-05-23 | 2020-05-22 | Nanoparticles comprising enzalutamide |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025071092A Division JP2025118693A (ja) | 2019-05-23 | 2025-04-23 | エンザルタミドを含むナノ粒子 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022533463A JP2022533463A (ja) | 2022-07-22 |
| JPWO2020234448A5 JPWO2020234448A5 (https=) | 2023-05-29 |
| JP2022533463A5 true JP2022533463A5 (https=) | 2023-05-29 |
Family
ID=70861458
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021569958A Pending JP2022533463A (ja) | 2019-05-23 | 2020-05-22 | エンザルタミドを含むナノ粒子 |
| JP2025071092A Pending JP2025118693A (ja) | 2019-05-23 | 2025-04-23 | エンザルタミドを含むナノ粒子 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025071092A Pending JP2025118693A (ja) | 2019-05-23 | 2025-04-23 | エンザルタミドを含むナノ粒子 |
Country Status (5)
| Country | Link |
|---|---|
| US (2) | US20220249388A1 (https=) |
| EP (1) | EP3972569A1 (https=) |
| JP (2) | JP2022533463A (https=) |
| CA (1) | CA3141534A1 (https=) |
| WO (1) | WO2020234448A1 (https=) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3915546A1 (de) * | 2020-05-25 | 2021-12-01 | Leon-Nanodrugs GmbH | Verwendung von säure als lösungsmittel für präzipitationen |
| WO2024127361A1 (en) * | 2022-12-16 | 2024-06-20 | Ferring B.V. | Enzalutamide nanocrystals, methods and compositions |
| EP4651860A1 (en) | 2023-01-18 | 2025-11-26 | HELM Pharmaceuticals GmbH | Crystalline nanoparticles comprising enzalutamide |
Family Cites Families (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5399363A (en) * | 1991-01-25 | 1995-03-21 | Eastman Kodak Company | Surface modified anticancer nanoparticles |
| US5534270A (en) | 1995-02-09 | 1996-07-09 | Nanosystems Llc | Method of preparing stable drug nanoparticles |
| US5833891A (en) | 1996-10-09 | 1998-11-10 | The University Of Kansas | Methods for a particle precipitation and coating using near-critical and supercritical antisolvents |
| TW486370B (en) | 1996-12-25 | 2002-05-11 | Yamanouchi Pharma Co Ltd | Rapidly disintegrable pharmaceutical composition |
| ATE364374T1 (de) | 1997-08-11 | 2007-07-15 | Pfizer Prod Inc | Feste pharmazeutische dispersionen mit erhöhter bioverfügbarkeit |
| CA2335472C (en) | 1998-06-19 | 2008-10-28 | Rtp Pharma Inc. | Processes to generate submicron particles of water-insoluble compounds |
| AU4910300A (en) | 1999-04-08 | 2000-11-14 | Bernd Penth | Method and device for carrying out chemical and physical processes |
| CA2436418A1 (en) | 2001-01-30 | 2002-08-08 | Board Of Regents, The University Of Texas Systems | Process for production of nanoparticles and microparticles by spray freezing into liquid |
| CA2435721A1 (en) | 2001-01-31 | 2002-08-08 | Kraft Foods Holdings, Inc. | Production of capsules and particles for improvement of food products |
| ES2257968B1 (es) | 2005-01-28 | 2007-07-01 | Universidad De Sevilla | Procedimiento y dispositivo para la obtencion de particulas de tamaño micro y nanometrico. |
| DE102005017777A1 (de) | 2005-04-13 | 2006-10-19 | Pharmasol Gmbh | Verfahren zur schonenden Herstellung von hochfeinen Partikelsuspensionen |
| US7709517B2 (en) | 2005-05-13 | 2010-05-04 | The Regents Of The University Of California | Diarylhydantoin compounds |
| DE102005053862A1 (de) | 2005-11-04 | 2007-05-10 | Pharmasol Gmbh | Verfahren und Vorrichtung zur Herstellung hochfeiner Partikel sowie zur Beschichtung solcher Partikel |
| DE102009008478A1 (de) | 2009-02-11 | 2010-08-19 | PHAST Gesellschaft für pharmazeutische Qualitätsstandards mbH | Vorrichtung und Verfahren zur Herstellung pharmazeutisch hochfeiner Partikel sowie zur Beschichtung solcher Partikel in Mikroreaktoren |
| EP2550092B1 (de) | 2010-03-22 | 2018-08-15 | Instillo GmbH | Verfahren zur herstellung von mikro- oder nanopartikeln |
| WO2014043208A1 (en) | 2012-09-11 | 2014-03-20 | Medivation Prostate Therapeutics, Inc. | Formulations of enzalutamide |
| US9901893B2 (en) | 2013-03-28 | 2018-02-27 | Instillo Gmbh | Apparatus and method for producing dispersions and solids |
| CA2940984A1 (en) * | 2014-02-05 | 2015-08-13 | Lek Pharmaceuticals D.D. | Solid pharmaceutical compositions of androgen receptor antagonists |
| DE102016101232A1 (de) | 2016-01-25 | 2017-07-27 | Instillo Gmbh | Verfahren zum Herstellen von Emulsionen |
| WO2019155416A2 (en) * | 2018-02-09 | 2019-08-15 | Kashiv Pharma Llc | A stable pharmaceutical composition of poorly soluble nonsteroidal antiandrogens |
-
2020
- 2020-05-22 EP EP20728700.4A patent/EP3972569A1/en active Pending
- 2020-05-22 US US17/612,863 patent/US20220249388A1/en not_active Abandoned
- 2020-05-22 WO PCT/EP2020/064268 patent/WO2020234448A1/en not_active Ceased
- 2020-05-22 CA CA3141534A patent/CA3141534A1/en active Pending
- 2020-05-22 JP JP2021569958A patent/JP2022533463A/ja active Pending
-
2025
- 2025-04-23 JP JP2025071092A patent/JP2025118693A/ja active Pending
- 2025-05-05 US US19/198,832 patent/US20250262166A1/en active Pending